EMail PageAdd To Your FavoritesPrint Page
Publications
URMC

Publications by Author

Anirban Bose, M.D.

Publications

1 Bose A, Yoshihiko I, Kokko Kenneth, Lakkis FG. Control of the Alloimmune Response by Perforin bearing CD8 Cells. Submitted for publication

2 Martin S. Zand, Anirban Bose, Ben Briggs. Computer Simulation of CD4+ T Cell activation kinetics using a Discrete Event Stochastic Model. Submitted for publication

Abstracts

1 Anirban Bose MD, Yoshihiko Inoue MD, Kenneth Kokko MD, Fadi G LakkisMD Failure to Induce Allograft Acceptance in Peforin Deficient (PfP) mice: Renal Division Emory University and Veterans Administration Medical Center, Atlanta , GA. Oral and poster presentation Transplant 2001

2 Anirban Bose MD, Yoshihiko Inoue MD, Kenneth Kokko MD, Fadi G LakkisMD. Perforin is essential for the regulation of the alloimmune Response. Dept of Medicine sections of Nephrology and Immunobiology, Yale University, New Haven CT. Poster presentation, American Society of Nephrology and World Congress of Nephrology, Oct 2001

Reviews and Chapters

1 Bose A, Akalin E and Lakkis FG,. Cytokines in Heart transplantation. Heart Transplantation.Mitchell R et Al (editors) In press

David A. Bushinsky, M.D.

Original Peer Reviewed Research Publications

1. Krieger, N. S., W. P. Parker, K. M. Alexander, and D. A. Bushinsky. Prostaglandins regulate acid-induced cell-mediated bone resorption. Am. J. Physiol. (Renal Physiol.) 279:F1077-F1082, 2000.

2. Bushinsky, D. A., M. D. Grynpas and J. R. Asplin. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Intl, 59:1415-1423, 2001.

3. Bushinsky, D. A., W. P. Parker, K. M. Alexander and N. S. Krieger. Metabolic, but not respiratory, acidosis increases bone prostaglandin E2 levels and calcium release. Am. J. Physiol. Renal Physiol. 281:F1058-F1066, 2001.

4. Bushinsky, D. A., J. R. Asplin, M. D. Grynpas, A. P. Evan, W. R. Parker, K. M. Alexander and F. L. Coe. Calcium oxalate stone formation in genetic hypercalciuric stone forming rats. Kidney Intl, 61: 975-987, 2002.

5. Krieger, N. S., K. K. Frick, W. R. Parker and D. A. Bushinsky. Cortisol inhibits acid-induced bone resorption in-vitro. J Am Soc Nephrol, 13: 2534-2539, 2002.

6. Bushinsky, D. A., S. B. Smith, K. L. Gavrilov, L. F. Gavrilov, J. Li and R. Levi-Setti. Acute acidosis-induced alteration in bone bicarbonate and phosphate. Am. J. Physiol. Renal Physiol, 283: F1091-F1097, 2002.

7. Quarles, L. D., D. J. Sharrard, S. Adler, S. J. Rosansky, L. C. McCary, W. Liu, S. A. Turner and D. A. Bushinsky. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J. Am Society of Neph. 14: 575-583, 2003.

8. Frick, K. K. and D. A. Bushinsky. Metabolic acidosis stimulates RANK ligand RNA expression in bone through a cyclo-oxygenase-dependent mechanism. J. Bone and Mineral Res. 18:1317-1325, 2003.

9. Hoopes, R. R., R. Reid, S. Sen, C. Szpirer, P. Dixon, A. Pannet, R. V. Thakker, D. A. Bushinsky, S. J. Scheinman. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J. Am Society of Neph. 14: 1844-1850, 2003.

10. Bushinsky, D. A., S. B. Smith, K. L. Gavrilov, L. F. Gavrilov, J. Li and R. Levi-Setti. Chronic acidosis-induced alteration in bone bicarbonate and phosphate. Am. J. Physiol. Renal Physiol, 285: F532-F539, 2003.

11. Lemann, J. Jr., D. A. Bushinsky and L. Hamm. Bone buffering of acid and of base in humans. Am. J. Physiol. Renal Physiol, 285: F811-F832, 2003.

12. Evan, A. P., S. Bledsone, S. B. Smith and D. A. Bushinsky. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Intl. 65:154-161, 2004.

13. Bushinsky, D. A., and J. R. Asplin. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. J. Am. Soc. 16: 417-424, 2005.

14. Karnauskas, A. J., J. P. T. M. van Leeuwen; G. J. C. M. van den Bemd, P. P. Kathpalia, H. F. DeLuca, D. A. Bushinsky, M. J. Favus. Mechanism and Function of High Vitamin D Receptor Levels in Genetic Hypercalciuric Stone-Forming Rats. J. Bone and Mineral Res. In press. J. Am. Soc. Neph.

15. Yao, J. J., A. J. Karnauskas, D. A. Bushinsky and M. J. Favus. Regulation of renal calcium-sensing receptor gene expression by 1,25(OH)2D3 in genetic hypercalciuric stone forming rats. In press. J. Am. Soc. Neph.

16. Bushinsky, D. A., and J. R. Asplin. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. J. Am. Soc. 16: 417-424, 2005.

17. Martin, K. J., H. Juppner, D. J. Sherrard, W. Goodman, M. R. Kaplan, G. Nassar, P. Campbell, M. Curzi, C. Charytan, L. C. McCary, M. D. Guo, S. A. Turner and D. A. Bushinsky. First- and second-generation PTH assays to assess cinacalcet HCl efficacy for secondary hyperparathyroidism. In revision. Kidney Intl.

18. Frick, K. K., LaPlante, K. and D. A. Bushinsky. RANK ligand and TNF-a mediate acid-induced bone calcium efflux in vitro. In revision, Am. J. Physiol.

19. Grynpas, M., A. Ng, S. Waldman, S. X. Wang and D. A. Bushinsky. Bone quality in genetic hypercalciuric stone forming rats. In preparation.

Book

1. Renal Osteodystrophy, edited by D. A. Bushinsky. Philadelphia: Lippincott-Raven. 1998. pp 1-514.

Editor

1. NKF MD, M. Levi and D. A. Bushinsky, eds. 1999-2002

Guest Editor

1. Kidney Stones, Seminars in Nephrology, D. A. Bushinsky, ed. 16: 1996.

2. Electrolyte Quintet, The Lancet, D. A. Bushinsky, ed. 352: 1998.

3. Calcium, Current Opinion in Nephrology and Hypertension, J. Silver and D. A. Bushinsky, eds. 1999.

4. Calcium: Discovering the Details, Current Opinion in Nephrology and Hypertension, D. A. Bushinsky and J. Silver, eds. 2000.

5. Calcium, Current Opinion in Nephrology and Hypertension, J. Silver and D. A. Bushinsky, eds. 2001.

6. Calcium, Current Opinion in Nephrology and Hypertension, J. Silver and D. A. Bushinsky, eds. 2002.

7. Calcium, Current Opinion in Nephrology and Hypertension, J. Silver and D. A. Bushinsky, eds. 2003.

8. Calcium, Current Opinion in Nephrology and Hypertension, J. Silver and D. A. Bushinsky, eds. 2004.

9. Calcium, Current Opinion in Nephrology and Hypertension, D. A. Bushinsky and J. Silver, eds. 2005 - in preparation

Electronic Media

"Acid Base and the Skeleton"
David A. Bushinsky
www.hdcn.com/symp/99phos/99phos.htm

"Nephrotic Syndrome"
David A. Bushinsky
WebMD.com

Commentary for Bone KEY
"The Acid Test for Bone"
David A. Bushinsky -
http://www.bonekey-ibms.org/cgi/content/full/ibmske;20040124

Invited Chapters and Ariticles

  1. Monk, R.D. and Bushinsky, D. A. Approach to the Patient with Renal Lithiasis. In: Kelly's Textbook of Medicine, edited by D. Humes. New York, J. B. Lippincott Co. 2000, 1119-1124.
  2. Bushinsky, D. A. Renal Lithiasis. In: Kelly's Textbook of Medicine, edited by D. Humes. New York, J. B. Lippincott Co. 2000, 1243-1248 .
  3. Bushinsky, D. A. and K. K. Frick. Effects of Acid on Bone. Current Opinion in Nephrology and Hypertension. 9:369-379, 2000.
  4. Bushinsky, D. A. Bench to Bedside: Lessons from the Genetic Hypercalciuric Stone Forming Rat. Am J of Kidney Disease, 36: LXI-LXIV, 2000.
  5. Derman M. and D. A. Bushinsky. Medical Management of Kidney Stone Dissorders. In: Medical Management of Kidney and Electrolytes Disorders. F. G. Gennari editor. In press.
  6. Bushinsky, D. A. Disorders of Calcium and Phosphorus Homeostasis. In: Nephrology Primer, edited by A. Greenberg. New York, Academic Press, Third edition, 2001, 107-115.
  7. Bushinsky, D. A. Dysregulation of the Calcium, Phosphorus, PTH, Vitamin D Axis: What are the causes and risks? Am J of Kidney Disease, 37:1310-1312, 2001.
  8. Bushinsky, D. A. Acid-Base Imbalance and the Skeleton. European Journal of Nutrition. 40: 238-244, 2001.
  9. Bushinsky, D. A. Kidney Stones. Advances in Internal Medicine. 47:219-238, 2001.
  10. Krieger, N.S. and Bushinsky, D. A. Effects of Acidosis on Bone, Dialysis Times. In press.
  11. Bushinsky, D. A. and N. S. Krieger. Integration of Mineral Metabolism in the Adult. In: Disorders of Bone and Mineral Metabolism, edited by F. L. Coe and M. J. Favus. New York, Lippincott Williams & Wilkins, in press.
  12. Bushinsky, D. A. Recurrent hypercalciuric nephrolithiasis: Does diet help? N. Engl. J. Medicine. 346: 124-125, 2002.
  13. Monk, R.D. and Bushinsky, D. A. Nephrolithiasis. In: William's Textbook of Endocrinology, 10th edition, edited by Larsen, Kronenberg, Malmed and Polonsky. Philadelphia, W. B. Saunders 2003, 1411-1425.
  14. Bushinsky, D. A. Nephrolithiasis: Site of the Initial Solid Phase. J. Clin. Invest. 111:602-605, 2003.
  15. Sensing Ions, Secreting Hormones and the Structure of Bone, Current Opinion in Nephrology and Hypertension, D. A. Bushinsky and J. Silver eds. 2003.
  16. Monk, R. D. and D. A. Bushinsky. Nephrolithiasis and Nephrocalcinosis. In: Comprehensive Clinical Nephrology. edited by R. J. Johnson and John Feehally. Mosby, London. 2nd edition, 2003, 731-744.
  17. Bushinsky, D. A. Calcium, Magnesium, and Phosphorus: Renal Handling and Urinary Excretion. In: Primer of Metabolic Bone Diseases and Disorders of Mineral Metabolism, edited by M. Favus. Philadelphia, Lippincott-Raven, 5th edition, 2003, 97-105.
  18. Frick K. K. and D. A. Bushinsky. Molecular Mechanisms of Primary Hypercalciuria.
    J. Am. Society of Neph. 14:1082-1095, 2003.
  19. Bushinsky, D. A. Acid-Base Imbalance and the Skeleton. In: Nutrition and Bone Health edited by M. F. Holick and B. Dawson-Hughes. Humana Press. In press.
  20. Krieger, N. S., D. A. Bushinsky and K. K. Frick. Cellular Mechanisms of Bone Resorption Induced by Metabolic Acidosis. Semin. Dialysis. In press.
  21. Silver, J. and D. A. Bushinsky. Harnessing the parathyroids to create stronger bones. Curr Opin Nephrol Hypertens. 13: 471-476, 2004.
  22. Bushinsky, D. A. Disorders of Calcium and Phosphorus Homeostasis. In: Nephrology Primer, edited by A. Greenberg. New York, Academic Press, Fourth edition, 2005, in press.
  23. Krieger, N.S., Frick, K.K. and D. A. Bushinsky Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens. 13: 423-436, 2004.
  24. Silver J and D. A. Bushinsky Harnessing the parathyroids to create stronger bones. Curr Opin Nephrol Hypertens. 13: 471-476, 2004.

Abstracts

  1. Bushinsky, D. A., K. L. Gavrilov, J. M. Chabala and R. Levi-Setti. Contribution of organic material to the ion composition of bone. J. Amer. Soc. of Nephrology, 11:A2921, 2000 (presented).
  2. Frick, K. K., W. P. Parker, G. Karsenty, T Schinke and D. A. Bushinsky. Increased basal calcium efflux from bone deficient in matrix Gla protein. J. Amer. Soc. of Nephrology, 11:A2969, 2000 (presented).
  3. Krieger, N. S., W. P. Parker, K. M. Alexander, and D. A. Bushinsky. Prostaglandin synthesis regulates cell-mediated, acid-induced bone resorption. J. Amer. Soc. of Nephrology, 11:A2988, 2000 (presented).
  4. Bushinsky, D. A., K. L. Gavrilov, J. M. Chabala and R. Levi-Setti. Contribution of organic material to the ion composition of bone. J. Bone and Mineral Research, 15: 2000 (presented).
  5. Frick, K. K., W. P. Parker, G. Karsenty, T Schinke and D. A. Bushinsky. Absence of matrix Gla protein increases basal calcium efflux from calvariae in vitro. J. Bone and Mineral Research, 15: 2000 (presented).
  6. Krieger, N. S., W. P. Parker, K. M. Alexander, and D. A. Bushinsky. Bone resorption induced by metabolic acidosis is mediated by prostaglandin synthesis. J. Bone and Mineral Research, 15: 2000 (presented).
  7. Quarles, L. D., D. J. Sherrard, S. Adler, S. J. Rosansky, L. C, McCary, R. M. Brenner, W. Liu, S. A. Turner and D. A. Bushinsky. The calcimimetic AMG 073 reduces PTH and Ca x P in patients with secondary hyperparathyroidism. J. Amer. Soc. of Nephrology, 12: 771A, 2001 (presented).
  8. Krieger, N. S., W. R. Parker, S. B. Smith and D. A. Bushinsky. Inhibition of cyclooxygenase 2 (COX2) prevents acid-induced calcium efflux from bone. J. Amer. Soc. of Nephrology, 12:744A, 2001 (presented).
  9. Bushinsky, D. A., W. R. Parker, K. M. Alexander and N. S. Krieger. Metabolic, but not respiratory, acidosis increases bone prostaglandin E2 level and calcium release. J. Amer. Soc. of Nephrology, 12: 741A, 2001 (presented).
  10. Bushinsky, D. A., J. R. Asplin, M. D. Grynpas, A. P. Evan, W. R. Parker, K. M. Alexander and F. L. Coe. Calcium oxalate stone formation in the genetic hypercalciuric stone-forming rat. J. Amer. Soc. of Nephrology, 12: 751A, 2001 (presented).
  11. Hoopes, R. R., R. Reid, R. V. Thakker, D. A. Bushinsky and S. J. Scheinman. Gender-specific genetic linkage for hypercalciuria in the genetic hypercalciuric stone-forming (GHS) rat. J. Amer. Soc. of Nephrology, 12: 74A, 2001 (presented).
  12. Frick, K. K. and D. A. Bushinsky. Metabolic acidosis stimulates expression of Rank Ligand RNA. J. Amer. Soc. of Nephrology 2002 (presented).
  13. Bushinsky, D. A., S. B. Smith, K. L. Gavilov, L. F. Gavrilov, J Li and R. Levi-Setti. Acute acidosis-induced alteration in bone bicarbonate and phosphate. J. Amer. Soc. of Nephrology 2002 (presented).
  14. Evan, E. P., S. B. Bledsoe, S. B. Smith, W. R. Parker, D. A. Bushinsky. Localization of Calcium Phosphate/Calcium Oxalate Crystals and Osteopontin Immunostaining in Kidneys from Genetic Hypercalciuric Stone Forming Rats. J. Amer Soc. of Nephrology 2002 (presented).
  15. Frick, K. K. and D. A. Bushinsky. Metabolic acidosis stimulates expression of Rank Ligand RNA. J. Bone and Min. Res. 2002 (presented).
  16. Bushinsky, D. A., S. B. Smith, J. M. Chabala, K. L. Gavilov and R. Levi-Setti. Acidosis-induced alteration in bone bicarbonate and phosphate. J. Bone and Min. Res. 2002 (presented).
  17. Evan, E., S. Bledsoe, S. Smith, W. Parker, D. Bushinsky. Crystal Localization and osteopontin immunostaining in genetic hypercalciuric stone forming rats. J. Urology 2003 (presented).
  18. Frick, K. K., S. B. Smith, D. A. Bushinsky. RANKL and TNF-a contribute to acid-induced bone calcium efflux. J. Bone and Min. Res. 2003 (presented).
  19. Bushinsky, D. A., S. B. Smith, F. L. Coe and J. R. Asplin. Chlorthalidone reduces urine calcium, calcium phosphate supersaturation and stone formation in genetic hypercalciuric stone forming rats. J. Bone and Min. Res. 2003 (presented).
  20. Krieger, N. S. and D. A. Bushinsky. Regulation of COX-2 mRNA expression in bone by metabolic acidosis. J. Bone and Min. Res. 2003 (presented).
  21. Hoopes, R. R., S. Sen, R. Reid, D. A. Bushinsky, and S. J. Scheinman. Genetic loci linked to hypercalciuria in a rat model of kidney stone disease. J. Amer. Soc. of Nephrology 2003 (presented).
  22. Martin, K. J., D. J. Sherrard, M. Kaplan, G. Nassar, P. Campbell, M. Curzi, L. C. McCary, K. A. Olson, S. A. Turner and D. A. Bushinsky. Control of bio-intact parathyroid hormone (PTH) levels with the calcimimetic, cinacalcet HCL, in hemodialysis patients with secondary hyperparathyroidism (HPT). J. Amer. Soc. of Nephrology 2003 (presented).
  23. Frick, K. K., S. B. Smith, D. A. Bushinsky. RANKL and TNF-a contribute to acid-induced bone calcium efflux. J. Amer. Soc. of Nephrology 2003 (presented).
  24. Bushinsky, D. A., S. B. Smith, F. L. Coe and J. R. Asplin. Chlorthalidone reduces urine calcium, calcium phosphate supersaturation and stone formation in genetic hypercalciuric stone forming rats. J. Amer. Soc. of Nephrology 2003 (presented).
  25. Krieger, N. S. and D. A. Bushinsky. Regulation of COX-2 mRNA expression in bone by metabolic acidosis. J. Amer. Soc. of Nephrology 2003 (presented).
  26. Frick, K.K., N. S. Krieger, K. LaPlante, S. B. Smith, and D. A. Bushinsky. Decreased acid-Induced bone resorption in COX-2 knockout mice. J Bone Min Res, 2004.
  27. Krieger, N.S., LaPlante,K., Sullivan,J. and Bushinsky,D.A. Phosphatidylinositol 3-kinase pathway is stimulated by metabolic acidosis. J. Bone Min. Res. 2004 (presented).
  28. Frick, K. K., N. S. Krieger, K. LaPlante , S. B. Smith and D. A. Bushinsky. Acid-induced calcium efflux from bone is inhibited in COX-2 knockout mice. J. Amer. Soc. of Nephrology 2004 (presented).
  29. Nehrke K., K. K. Frick, N. S. Krieger, T. Sherman and D. A. Bushinsky. Global analysis of gene expression in bone following metabolic acidosis. J. Amer. Soc. of Nephrology 2004 (presented).
  30. Nehrke K., K. K. Frick, N. S. Krieger, T. Sherman and D. A. Bushinsky. Global analysis of kidney gene expression in the genetic hypercalciuric stone forming (GHS) rat. J. Amer. Soc. of Nephrology 2004 (presented).
  31. Krieger, N. S., K. LaPlante, J. Sullivan and D. A. Bushinsky. Metabolic acidosis stimulation of bone resorption involves the phosphatidylinositol 3 Kinase/Akt pathway. J. Amer. Soc. of Nephrology 2004 (presented).

 

 Richard A. Demme, M.D.

Publications-Book Chapters

The Ethics of Xenotransplantation
In The Ethics of Organ Transplantation, Edited by Wayne Shelton and John Balint, p 195-229. Elsevier Science Inc, 2001. ISBN: 0-7623-0764-1.

Publications-Journals

1. Zand,MS, and Demme,RA. Halt the Bidding: A Response to Dr. Kevorkian's Proposal.
American Journal of Forensic Psychiatry, Vol 22, Issue 2, 2001:24-36.
Demme,RA. Hypertension in the Kidney Transplant Patient. Graft 2001;4:248-255.

2. Hijazi,F, Zand,MS, and Demme, RA. Long-Term Management of Post-Transplant Anemia and Erythrocytosis. Graft 2001;4:307-315.

3. Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS.Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation. 2004 May 15;77(9):1399-405.

4. Demme,RA. Truth and Consequences in an Era of "Unsurance." AJOB Fall 2004;4:69-71.

Abstracts and Presentations

1. Who Lives, Who Dies, What's Changed? Problematic Cases in Dialysis and Transplantation. Presented at the University of Rochester Medical Center Interdisciplinary
Clinical Ethics Rounds, April, 2000.

2. Hypertension and Renal Insufficiency after Organ Transplantation. Presented at University of Rochester Continuing Professional Education Seminar--Primary Care of the Well Transplant Patient. 4 Nov. 2000.

3. Separating the Conjoined Twins: Solomon's Decision? A discussion on the British Court
ruling on the division of "Siamese" twins. Presented at the University of Rochester
Interdisciplinary Clinical Ethics Rounds. 14 March, 2001.

4. Who Lives, Who Dies, What's Changed? Ethical Dilemmas in Dialysis and
Transplantation. Presented at the Annual Nephrology Teaching Day 2001, Great
Lakes Chapter of the American Nephrology Nurses Association. 1 April, 2001.

5. A Brief Introduction to Ethics and End of Life Issues. Presented at the Third Presbyterian Church, Rochester, NY, 3 June, 2001.

6. End Stage Renal Disease and Withdrawal of Dialysis. Presented at URMC Palliative Care Conference Series. 24 April, 2002

7. Advantages of Having a Terminal Diagnosis: Clinical Problems With Advance Directives. Presented at URMC Palliative Care Conference Series. 25 April, 2002

8. Medical Ethics Overview; Advance Directives; Ethical Issues in Transplantation
Seminar Series, Adult Education, Faith Lutheran Church. Fall, 2003.

9. Truth-Telling in Medicine: White Coats and "White Lies." Presented at University of Rochester Interdisciplinary Clinical Ethics Rounds. 14 Jan, 2004.

 

Kevin K. Frick, Ph.D.

Original Articles

  1. 1. Dey, B.R., Frick, K.K., Lopaczynski, W., Nissley, S.P. and Furlanetto, R.W. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, SHC, and GRB10. Molecular Endocrinology 10 (6): 631-641, 1996.
  2. Frick, K.K., Jiang, L. and Bushinsky, D.A. Acute metabolic acidosis inhibits the induction of osteoblastic Egr-1 and type I collagen. American Journal of Physiology (Cell Physiology) 272: C1450-C1456, 1997.
  3. Furlanetto, R. W., Frick, K.K., Dey, B.R., Lopaczynski, W., Terry, C and Nissley, S.P. The yeast receptor two-hybrid system to investigate IGF-1 receptor signal transduction. In: Molecular Mechanisms to Regulate the Activities of Insulin-like Growth Factors. K. Takano, N. Hizuka and S.I. Takahashi, Ed. Elsevier: Amsterdam, 1998, pp. 269-277.
  4. Nissley, S.P., Dey, B.R., Frick, K.K., Lopaczynski, W., Terry, C. and Furlanetto, W. Differences between insulin and IGF-1 signaling. In: Molecular Mechanisms to Regulate the Activities of Insulin-like Growth Factors, K. Takano, N. Hizuka and S.I. Takahashi, Ed. Elsevier: Amsterdam, 1998, pp 291-300.
  5. Frick, K.K. and Bushinsky, D.A. Chronic metabolic acidosis reversibly inhibits extracellular matrix gene expression in mouse osteoblasts. Am J Physiol (Renal Physiol) 275:F840-F847, 1998.
  6. Frick, K.K., and Bushinsky, D.A. In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression. Am J Physiol (Renal Physiol) In Press.

Abstracts

  1. Frick, K.K., Jiang, L. and Bushinsky, D.A. Regulation of osteoblastic gene expression by pH. Presented at the American Society for Bone and Mineral Research 18th Annual Meeting, Seattle, WA, September 1996.
  2. Frick, K.K. and Bushinsky, D.A. Metabolic alkalosis augments osteoblastic collagen RNA levels. Presented at the American Society of Nephrology 29th Annual Meeting, New Orleans, LA, November 1996.
  3. Frick, K.K. and Bushinsky, D.A. Chronic acidosis decreases bone cell expression of matrix component RNA. Submitted American Society of Nephrology 30th Annual Meeting, San Antonio, TX, November 1997.
  4. Frick, K.K. and Bushinsky, D.A. Effects of metabolic and respiratory acidosis on osteoblastic gene expression. Presented at 31st Annual Meeting, American Society of Nephrology, Philadelphia, PA, October 1998.
  5. Frick, K.K. and Bushinsky, D.A. Effect of simulated matrix on the response of osteoblasts to chronic metabolic acidosis. Presented at 31st Annual Meeting, American Society of Nephrology, Philadelphia, PA, October 1998.
  6. Frick, K.K. and Bushinsky, D.A. Effects of metabolic and respiratory acidosis on osteoblastic matrix gene expression. Presented at 2nd Joint Meeting of the American Society for Bone and Mineral Research and The International Bone and Mineral Society, San Francisco, CA, December 1998.
  7. Krieger, N.S., Parker, W., Frick, K.K., and Bushinsky, D. A. Effects of cortisol on acid-induced bone resorption in vitro (poster). (Presented at 32nd Annual Meeting, American Society of Nephrology, Miami Beach, FL, November 1999).
  8. Frick, K.K., Krieger, N.S., and Bushinsky, D.A. Acidosis does not modulate in vitro osteoblastic cytokine gene expression (poster). (Presented at 32nd Annual Meeting, American Society of Nephrology, Miami Beach, FL, November 1999).
Nancy S. Krieger, Ph.D.

Research Articles

  1. Krieger, N.S. Calcemic hormones regulate the level of sodium-calcium exchange protein in osteoblastic cells. Ann NY Acad Sci 779: 293-294, 1996.
  2. Krieger, N.S., Stathopoulos, V.M. and Bushinsky, D.A. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Amer J Physiol 271:C130-C135, 1996.
  3. Bushinsky, D.A., Gavrilov, K., Stathopoulos, V.M., Krieger, N.S., Chabala, J.M., and Levi-Setti, R. Effects of osteoclastic resorption on bone surface ion composition. Amer J Physiol 271:C1025-C1031, 1996.
  4. Krieger, N.S. Parathyroid hormone, prostaglandin E2 and 1,25-dihydroxyvitamin D3 decrease the level of Na+-Ca2+ exchange in protein in osteoblastic cells. Calc Tiss Int 60:473-478, 1997.
  5. Bushinsky, D.A., Riordon, D.R., Chan, J.S. and Krieger, N.S. Decreased potassium stimulates bone resorption. Amer J Physiol 272:F774-780, 1997.
  6. Bushinsky, D. A., Neumann, K., Asplin, J. and Krieger, N.S. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney International 55:234-243, 1999.

Book Chapters

  1. Bushinsky, D.A. and Krieger, N.S. Regulation of bone formation and resorption. In: Kidney Stones: Medical and Surgical Management, eds. Coe, F.L., Favus, M.J. Pak, C.Y.C., Parks, J.H. and Preminger, G.M. Lipponcott-Raven Publishers, Philadelphia, PA, 1996, pp. 239-258.
  2. Krieger, N.S. Bone formation, resorption and turnover. In: Renal Osteodystrophy, ed. Bushinsky, D.A. Lippincott-Raven Publishers, Philadelphia, PA, 1998, p.17-47.
  3. Krieger, N.S. Calcium and phosphorus. In: Renal Osteodystrophy, ed. Bushinsky, D. A., Lippincott-Raven Publishers, Philadelphia, PA, 1998. P.91-101.

Abstracts

  1. Krieger, N.S., Riordan, D. and Bushinsky, D.A. Both protein kinase C and protein kinase A signal transduction pathways mediate acid-induced bone resorption. J Bone Min Res, 12:S289, 1997.
  2. Krieger, N.S., Riordan, D. and Bushinsky, D.A. Acid-induced bone resorption is mediated by both protein kinase C and protein kinase A signal transduction pathways. J Amer Soc Neph. 8:553A, 1997.
  3. Bushinsky, D. A., Neymann, K., Asplin, J., Coe, F.L. and Krieger, N.S. Contribution of bone to hypercalciuria in genetic hypercalciuric rats. J Amer Soc Neph 8:559A, 1997.
  4. Krieger, N.S. and Bushinsky, D. A. Metabolic acidosis regulates MAP-kinase activity in primary bone cells. J Amer Soc Neph 9:546A, 1998.
  5. Krieger, N.S. and Bushinsky, D. A. Inhibition of MAP-kinase (MAPK) activity in primary bone cells by metabolic acidosis. Bone 23:S414, 1998.
  6. Krieger,N.S., Parker,W., Frick,K.K. and Bushinsky, D.A. Cortisol does not alter acid-induced bone resorption in vitro. J. Bone Min. Res. 14:S , 1999.
  7. Krieger,N.S., Parker,W., Frick,K.K. and Bushinsky,D.A. Effects of cortisol on acid-induced bone resorption. J. Amer. Soc. Neph. 10:599A, 1999.
  8. Frick,K.K., Krieger,N.S. and Bushinsky,D.A. Acidosis does not modulate in vitro osteoblastic gene expression. J. Amer. Soc. Neph. 10:598A.
Marc Lande, M.D.

Publications:

  1. Lande MB, Jo I, Zeidel ML, Somers M, Harris WH. Phosphorylation of Aquaporin-2 does not alter the membrane water permeability of rat papillary water channel-containing vesicles. J Biol Chem. J Biological Chem. 271(10):5552-7, 1996.
  2. Lande MB, Mowry JA, Houghton DC, White CR, Borzy MS. Immune complex disease associated with Epstein-Barr virus mononucleosis. Pediatr Nephrol 12:651-53, 1998.
  3. Soliday E, Kool E, Lande MB. Psychosocial adjustment in renal patients and healthy children. J Pediatr Psychol 25(2):93-103, 2000.
  4. Lashley DB, Barry JM, Demattos AM, Lande MB, Mowry JA. Kidney transplantation in children: A single center experience. J Urology 161 (6):1920-5, 1999.
  5. Soliday E, Grey S, Lande MB. Behavioral effects of corticosteroid therapy in childhood steroid-sensitive idiopathic nephrotic syndrome. Pediatrcs 104(4), 1999, URL: http://www.pediatrics.org/cgi/content/full/104/4/e51
  6. Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving corticosteroids. Pediatr Nephrol 14(4):305-8, 2000.
  7. Barry JM, Reller KS, Lande MB, Mowry JA, Jenkins R. Transplantation of adult kidneys into small children. Akt. Urol 29:239-45, 1998.
  8. Lande MB, Leonard M. Variability among pediatric nephrologists in the initial therapy of idiopathic nephrotic syndrome. Pediatr Nephrol 14:766-9, 2000.
  9. Brunner LJ, Pai K, Munar MY, Lande MB, Olyaei AJ, Mowry JA. Effect of grapefruit juice on cyclosporine pharmacokinetics in pediatric renal transplant patients. Pediatr Transplantation 4:313-321, 2000.
  10. Soliday E, Kool E, Lande MB. Family environment, child behavior, and medical indicators in children with kidney disease. Child Psychiatry and Human Development (in press).
  11. Soliday, E., Moore, K, J., Lande MB. Daily reports and pooled time series analysis: Pediatric psychology applications. Journal of Pediatr Psychol (in press)
  12. Soliday E, Lande MB. The effect of family structure on the course of steroid-sensitive nephrotic synrome. Pediatric Nephrology (in review).
  13. Lande MB, Houghton D, Thomas G. Membranous nephropathy associated with chronic ITP. AJKD 37:E40, 2001

In review:

  1. Lande MB, Gullion C, Hogg RJ, Leonard MB, Gauthier B. Arbus G. Long versus Standard Initial Steroid Therapy for Children with the Nephrotic Syndrome. A report from the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol

Abstracts not yet published in article form:

  1. Lande M, Gullion C, Roth L, Gauthier B, Strife F, Gray J, Nash M, Yadin O, Gharaybeh S, Bonilla-Felix M, Diven S, Leonard, for the SPNSG. Long versus standard prednisone therapy in children with steroid-sensitive nephrotic syndrome. Pediatric Nephrol 12;C155, 1998 (presented at the International Pediatric Nephrology Assoc., London meeting, Sept 1998).

Scott Liebman, M.D.

Publications

1. Liebman S, Teitelbaum I. Urinary Tract Obstruction in Textbook of Critical Care, 5th Edition. Edited by Mitchell Fink, Edward Abraham, Jean-Louis Vincent, and Patrick Kochanek

2. Liebman S, Teitelbaum I. Peritoneal Equilibration Tests Performed During The First Week Of PD Do Not Reliably Predict Membrane Transport Characteristics. Peritoneal Dialysis International 24 (Supp2), S16(Abstract), 2004

3. Liebman S, Jiang T, Halaihel N, Gittomer W, Lucia, MS, Levi M. Role of altered lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. (manuscript in preparation)

Rebeca D. Monk, M.D.

Publications


1. SHORT, C.L., MONK R.D., BUSHINSKY D.A., and KRIEGER N.S. Hormonal regulation of Na+-Ca2+ exchange in osteoblast-like cells. JBMR, 9: 1159-1166, 1994.

2. MONK R.D. Clinical approach to adults. Seminars in Nephrology (issue devoted to kidney stones), 16(5):375-388, September 1996.

3. MONK R.D. and BUSHINSKY D.A. Approach to the patient with renal lithiasis. In Textbook of Internal Medicine, third edition, W.N. Kelley, ed. Philadelphia, J.B. Lippincott Co. 1997, p 924-929.

4. MONK R.D. and BUSHINSKY D.A. Pathogenesis of Idiopathic Hypercalciuria. In Kidney Stones: Medical and Surgical Management. F. Coe, M. Favus, C. Pak, J. Parks, and G. Preminger, eds. Raven Press, New York, 1996.

5. GOTTLIEB R.H., WEINBERG E.P., RUBENS D.J., MONK R.D. and GROSSMAN E.B. Renal sonography: Can it be used more selectively in the setting of an elevated serum creatinine level? Amer. J. of Kidney Dis. 29(3): 362-367, 1997.

6. MONK R.D. and BUSHINSKY D.A. Treatment of Calcium, Phosphorus and Magnesium Disorders. In: Disorders of Fluid, Electrolyte and Acid-Base Homeostasis, edited by Brady H. and Wilcox C. Philadelphia, W. B. Saunders. 1998.

7. BUSHINSKY D.A. and MONK R.D. Calcium, The Lancet 352(9124): 306-311, 1998.

8. MONK R.D. and BUSHINSKY D.A. Nephrolithiasis and Nephrocalcinosis In: Comprehensive Clinical Nephrology, edited by R. J. Johnson and J. Feehally. Mosby, London. 1999, 60. Pp 60.1 - 60.12.

9. MONK R.D. and BUSHINSKY D.A. Approach to the patient with renal lithiasis. In, Kelley's Textbook of Internal Medicine, fourth edition, H.D.Humes, ed. Philadelphia, J.B. Lippincott Co., 2000.

10. MONK R.D. and BUSHINSKY D.A. Kidney Stones, in Williams' Textbook Endocrinology (in press), 2002.

11. REDDY S.S., SHERMAN A., and MONK R.D. Critically ill patients receiving
continuous renal replacement therapy: patient survival, renal function recovery and complications of therapy. Dialysis & Transplantation 31(11): 778-787, 2002.

12. MONK R.D. and BUSHINSKY D.A. Nephrolithiasis and Nephrocalcinosis In: Comprehensive Clinical Nephrology, edited by R. J. Johnson and J. Feehally. Mosby, London. Second edition, 2003.

13. Sloand J.A., Shelly M.A., Feigin A., Bernstein P., MONK R.D. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Amer .J. of Kidney Dis. 43(4): 663-670, 2004.

Abstracts

1. KRIEGER N.S., MONK R.D., SHORT C.L. and BUSHINSKY D.A. Sodium/calcium exchange in osteoblasts is regulated by PTH and PGE2. 12th International Congress of Nephrology. Jerusalem, Israel, June 1993.

2. MONK R.D. and KRIEGER N.S. Inhibition of bidirectional sodium/calcium exchange in osteoblasts by calcemic agents. American Society for Bone and Mineral Research, October 1993

3. MONK R.D., BUSHINSKY D.A. and KRIEGER N.S. Bidirectional sodium/calcium exchange in osteoblasts is inhibited by different classes of calcemic agents. 26th Annual Meeting of the ASN, November, 1993. (Poster presentation)

4. MONK R.D., FEIGIN A.S., SLOAND J.A.. Restless legs syndrome in patients with end stage renal disease: a case controlled study. Submitted to the 27th Annual Meeting of the ASN, October, 1994.

5. MONK R.D., BRIEN J.M., HOLLEY J.L. Mode of peritoneal dialysis as a predictor of noncompliance in peritoneal dialysis patients. Peritoneal Dialysis meeting, Seattle, February 1996.

6. SANKARASUBBAIYAN S., MONK R.D., HOLLEY J.L., ORNT D. Prevalence and severity of hypomagnesemia in renal transplant recipients on tacrolimus. Submitted to ASN October, 1998.

7. SANKARASUBBAIYAN S and MONK R.D. Hypomagnesemia and renal magnesium wasting in renal transplant patients on tacrolimus. Accepted as a poster presentation at the November 1999 American Society of Nephrology meeting, Miami Beach, Florida.

Sai Subhodhini Reddy, M.D.

Publications

1. Sai Subhodhini Reddy and JL Holley, "Nocardiosis in a Recently
Transplanted Renal Patient," Clin Neph 50: 123-127, 8/98

2. Sai Subhodhini Reddy and Daniel B. Ornt, "Permanent Dialysis Access
Placement in our Pre-ESRD Patients," Dialy and Transpl: 30: 142-6, 166, 3/01.

3. Sai Subhodhini Reddy, Arlene Sherman, and Rebeca Monk. "Critically Ill
Patients Receiving Continuous Renal Replacement Therapy: Patient Survival, Renal Function Recovery, and Complications of Therapy," Dialy and Transpl:31: 778-780, 784-787, 11/02.

4. Jean L. Holley and Sai Subhodhini Reddy, "Pregnancy in Dialysis Patients: A Review of Outcomes, complications, and Management," Semin in Dialy: 16: 398-402, 9-10/03.

Abstracts

1. Sai Subhodhini Reddy, Arline Sherman, and Rebeca Monk, "Patient Survival and
Renal Recovery in Critically Ill Patients on Continuous Renal Replacement Therapy," JASN 10: 179A, 9/99.

2. Sai Subhodhini Reddy, Linda Palm-Montalbano, David Waldman and Jean Holley, "A Comparison of Dialysis Treatments and Cost For the Bard, Tesio, and Optiflow Catheters," JASN:11; 1039, 9/00.

Chapters in Books

1. Janet Amico, Sai Subhodhini Reddy, and. Jean Holley, Current Cancer
Therapeutics Edition 4: Renal and Metabolic Complications of Cancer.
Current Medicine, Inc. Philadelphia, PA, 2001.

George J. Schwartz, M.D.

Selected References

1. Simpson AM, Schwartz GJ. Distal renal tubular acidosis with severe hypokalemia, probably caused by colonic H+-K+-ATPase deficiency. Arch Dis Child 2001;84:504-507.

2. Tsuruoka S , Nishiki K , Wakaumi M , Schwartz GJ , Fujimura A. Reduced nitric oxide production mediates cyclosporine A - induced distal renal tubular acidosis in rat . J Am Soc Nephrol 2002; 13:476A .

3. Schwartz GJ , Tsuruoka S , Vijayakumar S , Petrovic S , Mian A , Al-Awqati Q . Acid incubation reverses the polarity of intercalated cell transporters, an effect mediated by hensin . J Clin Invest 2002; 109 :89-99.

4. Schwartz GJ. Acid Base Considerations in Infants and Children. In: Acid-Base, Gennari FJ, Adrogue H, Galla JH, Madias NE (Eds). In Press, 2003.

5. Schwartz GJ. Potassium. In: Pediatric Nephrology. 5 th Ed., Avner ED, Harmon W, Niaudet P (Eds), Baltimore:William & Wilkins, Chapter 8, In press, 2003.

6. Watanabe, S., Tsuruoka, S., Vijayakumar, S., Fischer, G., Zhang, Y., Fujimura, A., Al-Awqati, Q., Schwartz, G.J.: Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin. Am. J. Physiol. In press, 2005.

Jeremy G.C.Taylor, M.D.

Publications:

1. C. Thomas Vangness, Jr., Michael Ennis, Jeremy G. Taylor, and Roscoe Atkinson. Neural Anatomy of the Glenohumeral Ligaments, Labrum and Subacromial Bursa. Arthroscopy. April 1995, 11(2): 180-184.

2. Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor JG, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW. Renal Dysfunction in Allogeneic Hematopoietic Cell Transplantation. Kidney International. 2002 August; 62(2): 566-73.

3. Taylor JG, Zwillich CW, Kaehny WD, Levi M, and Popovtzer MM. Hyperkalemia with
concomitant water diarrhea: an unusual association. American Journal of Kidney Diseases. August, 01, 2003; 42(2):E9-12

4. Chonchol M, Wachs M, Taylor J, Popovtzer MM. Should we biopsy kidneys of patients post-liver transplant? Transplant Proceedings. 2003 December;35(8):3035-8.

5. Berl T, Taylor J. Disorders of Water Balance. In: Fink M, Abraham E, Vincent J, Kochanek P, eds. Textbook of Critical Care, 5th edn. Philadelphia: Elsevier Sanders, 2005: 1085-96.

William S. Varade, M.D.

Original Articles

  1. Varade, W.S., Carnahan, J.A., Kingsley, P.D, and Insel R.A. Inherent properties of somatic hypermutation as revealed by human nonproductive VH6 immunoglobulin rearrangements. Immunology 1998;93:171-176.

Review

  1. Insel, R.A. and Varade, W.S. Characteristics of somatic hypermutation of human immunoglobulin genes. Current Topics in Microbiology and Immunology. 1998;229:33-44.

Abstracts

  1. Varade, W.S., Marin, E., and Insel, R.A. A prominent inherent characteristic of somatic mutation of human immunoglobulin genes is a transition vs. transversion bias. Keystone Symposium on Lymphocyte Activation. Hilton Head, South Carolina. March, 1996.
  2. Varade, W.S., Jones, J.A., Kingsley, P.D. and Insel, R.A. Somatic mutation (SM) of human immunoglobulin (Ig) heavy chain variable (V) region genes targets complementarity determining regions (CDR) in the absence of antigen (Ag) selection. Pediatr Res 1996;39:15A (Abstract 74).
  3. Varade, W.S., Carnahan, J., Marin, E., Kittelberger, A.M., and Insel, R.A. Gene conversion contributes to human antibody diversity. Pediatr Res 1997;41:13A (Abstract 61).
Martin S. Zand, Ph.D., M.D.

Original Reports

1. Zand MS, Li Y, Hancock WW, Li XC, , Roy-Chaudhury P, Zheng XX, Strom TB. IL-2 and IFN-g? double knockout mice reject heterotopic cardiac allografts. Transplantation 70(9):1378-1381, 2000.

2. Gross M, Zand MS, Nadasday T. Early renal allograft loss in a patient with crescentic glomerulonephritis in the native kidney. Am J Kid Dis, 37 (1):202-209, 2001.

3. Zand MS, Strang J, Dumlao M, Rubens D, Erturk E, Bronsther O. Screening a living-related kidney donor for polycystic kidney disease with heavily T2 weighted MRI. Am J. Kidney Dis 37(3):612-619, 2001.

4. Zand, MS, Demme R. Stop the bidding: A response to Dr. Kevorkian's proposal to auction human organs for transplantation. J. Forensic Psych. 22(2):47-55, 2001

5. Nadasdy T, Allen C, Zand MS. Zonal distribution of collapsing glomerulopathy in renal allografts. Possible role of vascular changes. Hum Pathol 33 (4): 437-441, 2002.

6. Schwimmer JA, Nadasdy T, Spitalnik P, Kaplan KL, Zand MS. De novo thrombotic microangiopathy (TMA) In renal transplant recipients: A comparison of hemolytic uremic syndrome with TMA localized to the allograft. Am J Kidney Dis 41:471-479, 2003.

7. Bozorgzadeh A, Jain A, Ryan C, Ornt D, Zand M, Mantry P, Lansing K, Orloff M. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living donor allograft in 100 consecutive liver transplant recipients under tacrolimus. Transplantation 77:1066-1070, 2004.

8. Shah A, Nadasdy T, Arend L, Brennan J, Leong N, Coppage M, Orloff M, Demme R, Zand MS. Treatment of C4d -positive acute humoral rejection with plasmapheresis and thymoglobulin results in excellent renal allograft survival. Transplantation 77(9):1399-1405, 2004.

9. Zand MS, Briggs BJ, Bose A, Vo, T. Discrete event modeling CD4+ memory T cell generation. J. Immunol, 173(6):3763-72., 2004.

10. Zand MS, Bose A, Vo T, Coppage M, Pelligrin T, Arend LA, Lee FE, Bozorgzadeh A, Leong N. A renewable source of donor cells for repetitive monitoring of T and B cell alloreactivity. Am J. Transplantation 5(1):76-86, 2005.

11. Zand MS, Bose A, Vo T, Coppage M, Pelligrin T, Arend LA, Lee FE, Bozorgzadeh A, Leong N. A renewable source of donor cells for repetitive monitoring of T and B cell alloreactivity. Am J. Transplantation 5(1):76-86, 2005.

12. Zand MS ,Vo T, Huggins J, Felgar R, Liesveld J, Pellegrin T, Bozorgzadeh A, Sanz I, Briggs B. Apoptosis of activated B cells and plasma cells induced by polyclonal anti-thymocyte globulin. Transplantation 77(11):1507-1515, 2005.

13. Komrokji RS, Oliva JL, Zand M, Felgar R, and Abboud CN. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders. Am J Hematol 79(3):211-215, 2005.

14. Shah A, Kendall G, Demme R, Taylor J, Bozorgzadeh A, Orloff M, Abt P, Jain A, Zand MS. Glucometer monitoring is required to diagnose post-transplant diabetes mellitus. Transplantation, 80(6):775-781, 2005.

15. Egbuna O, Zand MS, Taylor J. A Cluster of parvovirus B19 infections in renal transplant recipients. Am J Transplantation, 2005 [in press]

16. Vo T, Ifthikharuddin JJ, Felgar R, Abboud C, Liesveld JL, Zand, MS. Induction of myeloma cell apoptosis by polyclonal rabbit anti-thymocyte globulin (rATG). Blood, 2005 [in review].

17. Huggins J, Felgar R, Pellegrin T, Anolik J, Looney J, Sanz I, Zand MS. CpG DNA induces plasma cell differentiation of naïve CD27- human B cells. Blood, 2005 [in review].

 

Books and Book Chapters

1. Zand MS. Ethics for avoiding global catastrophe: Lessons from medicine, in The Human Predicament [Razis D, ed.] New York: Prometheus Press 1996;141-149.


Reports and Educationally Relevant Publications

1. Zand MS. The well-transplant recipient Graft 2001;4(4):222-223.

2. Abtahi P, Zand MS. Management of hyperlipidemia in the well transplant recipient. Graft 2001;4(4):258-266.

3. Schwimmer J, Zand, MS. Management of diabetes mellitus after solid organ transplantation. Graft 2001;4(4):248-276.

4. Hijazi F, Zand MS, Demme R. Management of post-transplant erythrocytosis and anemia. Graft 2001;4(4):299-307.

 

Proceedings of Meetings and Abstracts

1. Schwimmer JA, Nadasdy T, Kaplan KL, Zand MS. De Novo Thrombotic Microangiopathy (TMA) in Renal Transplant Recipients: A Comparison of Hemolytic Uremic Syndrome with TMA Localized to the Allograft. J Am Soc Neph. 2000; 11:725A.

2. Zand MS, Strang J, Dumlao M, Rubens D, Erturk E, Bronsther O. Screening a living-related kidney donor for polycystic kidney disease with heavily T2 weighted MRI. J Am Soc Neph. 2000;11:725A.

3. Zand MS, Suresh U, Sosnov J, Hijazi F, Nadasdy T, Orloff M, Demme R, Mieles L, Marcos A, Bronsther O. Incidence of biopsy proven chronic allograft nephropathy after corticosteroid withdrawal in renal transplant recipients on tacrolimus-based immunosuppression. Am J Transplantation 2001

4. Stycula W, Burton J, Zand M, Shaw-Stiffel M. Safe use of interferon ± ribavirin in the treatment of chronic hepatitis C pre- and post-renal transplantation. Eur Soc Hep, 2001.

5. Nadasdy T, Zand MS, Sephan R, Kohli R, Arend L, Vanderbilt K. Overlap of acute humoral rejection (AHR) and thrombotic microangiopathy (TMA): The value of C4d staining. J Am Soc Nephrol, 2001.

6. Zand MS, Shah A, Nadasdy T, Arend L, Brennen J, Suresh U, Orloff M, Demme R. Treatment of C4d -positive acute humoral rejection with plasmapheresis and thymoglobulin results in excellent renal allograft survival. Post-Transplant Immunusuppression, Minneapolis, MS. October 24, 2001.

7. Leong N, Coppage M, Shanahan T, Orloff M, Chen L, Massey T, Zand MS. False-positive post-transplant flow cytometric cross-match after polyclonal rabbit-anti thymocyte globulin treatment: A role for ELISA screening. Am Transplant Congress, 2002.

8. Zand MS, Orloff M, Shah A, Leong N, Coppage M, Nadasdy T, Arend L, Brennan J, Suresh U, Demme R. . Treatment of C4d -positive acute humoral rejection with plasmapheresis and polyclonal rabbit-anti-thymocyte globulin (rATG). Am Soc Clinical Oncology, June 7, 2004.

Alternate Media, Computer Software

1. Zand MS, Cannulli, M. Transplant Information System: A Relational Database for Clinical Management of Kidney, Pancreas, Liver, and Heart Transplant Recipients. 1998-2001.

2. Zand, MS. Mause Haus: A relational database for tracking transgenic mouse colonies. 2001.
 
 
© Copyright 2000-2006 University of Rochester Medical Center